Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
We are very excited to launch our new website! Please take a few moments to click around and explore...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...